Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2008

01.07.2008 | Clinical-Patient Studies

Atypical teratoid rhabdoid tumor (AT/RT) in adults: review of four cases

verfasst von: Addisalem T. Makuria, Elisabeth J. Rushing, Kevin M. McGrail, Dan-Paul Hartmann, Norio Azumi, Metin Ozdemirli

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Atypical teratoid/rhabdoid (AT/RT) tumor is a rare, highly malignant tumor of the central nervous system (CNS) most commonly found in children less than 5 years of age. Although the vast majority of cases are diagnosed in young children, there have been isolated case reports in adults. Since its histological appearance can be confused with other tumors, especially in adults, separating AT/RT from other neoplasms may be difficult. In many instances, a reliable diagnosis is not possible without demonstrating the lack of nuclear INI1 protein expression by immunohistochemical methods. The patients (three males and one female) ranged in age from 23 to 42 years (mean age, 32 years). Radiographically, two tumors were localized in the right fronto-parietal region, one was frontal and the other was found in the left temporal lobe. Varying degrees of hydrocephalus and heterogeneous enhancement were present on MRI. In all cases, diagnosis during intraoperative consultation and preliminary diagnosis was different from the final diagnosis after immunohistochemical analysis. Immunohistochemical staining showed that the tumor cells were positive for vimentin and reacted variably for keratin, epithelial membrane antigen (EMA), synaptophysin, neurofilament protein, CD34, and smooth muscle actin (SMA). All were negative for GFAP, S-100, desmin and CD99. Three of the four cases lacked nuclear expression of INI1. One patient is alive with no evidence of disease 17 years after the diagnosis. In adult examples of AT/RT, the diagnosis requires a high index of suspicion, with early tissue diagnosis and a low threshold for investigation with INI1 immunohistochemistry to differentiate this entity from other morphologically similar tumors. Although the prognosis is dismal in pediatric population, long term survival is possible in adult AT/RT cases after surgery and adjuvant radiotherapy and chemotherapy.
Literatur
1.
Zurück zum Zitat Beckwith JB, Palmer NF (1978) Histopathology and prognosis of Wilms tumors: results from the First National Wilms’ Tumor Study. Cancer 41:1937–1948PubMedCrossRef Beckwith JB, Palmer NF (1978) Histopathology and prognosis of Wilms tumors: results from the First National Wilms’ Tumor Study. Cancer 41:1937–1948PubMedCrossRef
2.
Zurück zum Zitat Haas JE, Palmer NF, Weinberg AG, Beckwith JB (1981) Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. Hum Pathol 12:646–657PubMedCrossRef Haas JE, Palmer NF, Weinberg AG, Beckwith JB (1981) Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. Hum Pathol 12:646–657PubMedCrossRef
3.
Zurück zum Zitat Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65PubMedCrossRef Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65PubMedCrossRef
4.
Zurück zum Zitat Zarovnaya EL, Pallatroni HF, Hug EB, Ball PA, Cromwell LD, Pipas JM, Fadul CE, Meyer LP, Park JP, Biegel JA, Perry A, Rhodes CH (2007) Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature. J Neurooncol 84:49–55PubMedCrossRef Zarovnaya EL, Pallatroni HF, Hug EB, Ball PA, Cromwell LD, Pipas JM, Fadul CE, Meyer LP, Park JP, Biegel JA, Perry A, Rhodes CH (2007) Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature. J Neurooncol 84:49–55PubMedCrossRef
5.
Zurück zum Zitat Horn M, Schlote W, Lerch KD, Steudel WI, Harms D, Thomas E (1992) Malignant rhabdoid tumor: primary intracranial manifestation in an adult. Acta Neuropathol (Berl) 83:445–448CrossRef Horn M, Schlote W, Lerch KD, Steudel WI, Harms D, Thomas E (1992) Malignant rhabdoid tumor: primary intracranial manifestation in an adult. Acta Neuropathol (Berl) 83:445–448CrossRef
6.
Zurück zum Zitat Fisher BJ, Siddiqui J, Macdonald D, Cairney AE, Ramsey D, Munoz D, Del Maestro R (1996) Malignant rhabdoid tumor of brain: an aggressive clinical entity. Can J Neurol Sci 23:257–263PubMed Fisher BJ, Siddiqui J, Macdonald D, Cairney AE, Ramsey D, Munoz D, Del Maestro R (1996) Malignant rhabdoid tumor of brain: an aggressive clinical entity. Can J Neurol Sci 23:257–263PubMed
7.
Zurück zum Zitat Ashraf R, Bentley RC, Awan AN, McLendon RE, Ragozzino MW (1997) Implantation metastasis of primary malignant rhabdoid tumor of the brain in an adult (one case report). Med Pediatr Oncol 28:223–227PubMedCrossRef Ashraf R, Bentley RC, Awan AN, McLendon RE, Ragozzino MW (1997) Implantation metastasis of primary malignant rhabdoid tumor of the brain in an adult (one case report). Med Pediatr Oncol 28:223–227PubMedCrossRef
8.
Zurück zum Zitat Arrazola J, Pedrosa I, Mendez R, Saldana C, Scheithauer BW, Martinez A (2000) Primary malignant rhabdoid tumour of the brain in an adult. Neuroradiology 42:363–367PubMedCrossRef Arrazola J, Pedrosa I, Mendez R, Saldana C, Scheithauer BW, Martinez A (2000) Primary malignant rhabdoid tumour of the brain in an adult. Neuroradiology 42:363–367PubMedCrossRef
9.
Zurück zum Zitat Kawaguchi T, Kumabe T, Watanabe M, Tominaga T (2004) Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult. Acta Neurochir (Wien) 146: 1033–1038 (discussion 1038)CrossRef Kawaguchi T, Kumabe T, Watanabe M, Tominaga T (2004) Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult. Acta Neurochir (Wien) 146: 1033–1038 (discussion 1038)CrossRef
10.
Zurück zum Zitat Lutterbach J, Liegibel J, Koch D, Madlinger A, Frommhold H, Pagenstecher A (2001) Atypical teratoid/rhabdoid tumors in adult patients: case report and review of the literature. J Neurooncol 52:49–56PubMedCrossRef Lutterbach J, Liegibel J, Koch D, Madlinger A, Frommhold H, Pagenstecher A (2001) Atypical teratoid/rhabdoid tumors in adult patients: case report and review of the literature. J Neurooncol 52:49–56PubMedCrossRef
11.
Zurück zum Zitat Pimentel J, Silva R, Pimentel T (2003) Primary malignant rhabdoid tumors of the central nervous system: considerations about two cases of adulthood presentation. J Neurooncol 61:121–126PubMedCrossRef Pimentel J, Silva R, Pimentel T (2003) Primary malignant rhabdoid tumors of the central nervous system: considerations about two cases of adulthood presentation. J Neurooncol 61:121–126PubMedCrossRef
12.
Zurück zum Zitat Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A (2005) Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Brain Pathol 15:23–28PubMedCrossRef Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A (2005) Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Brain Pathol 15:23–28PubMedCrossRef
13.
Zurück zum Zitat Rezanko T, Tunakan M, Kahraman A, Sucu HK, Gelal F, Akkol I (2006) Primary rhabdoid tumor of the brain in an adult. Neuropathology 26:57–61PubMedCrossRef Rezanko T, Tunakan M, Kahraman A, Sucu HK, Gelal F, Akkol I (2006) Primary rhabdoid tumor of the brain in an adult. Neuropathology 26:57–61PubMedCrossRef
14.
Zurück zum Zitat Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79PubMed Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79PubMed
15.
Zurück zum Zitat Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LB, Smith M (2002) Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 24:337–342PubMedCrossRef Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LB, Smith M (2002) Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 24:337–342PubMedCrossRef
16.
Zurück zum Zitat Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8: 3461–3467PubMed Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8: 3461–3467PubMed
17.
Zurück zum Zitat Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644–650PubMed Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644–650PubMed
18.
Zurück zum Zitat Byram D (1999) Regarding Weiss et al., IJROBP 41:103–109; 1998. Int J Radiat Oncol Biol Phys 45:247PubMed Byram D (1999) Regarding Weiss et al., IJROBP 41:103–109; 1998. Int J Radiat Oncol Biol Phys 45:247PubMed
19.
Zurück zum Zitat Sugita Y, Takahashi Y, Hayashi I, Morimatsu M, Okamoto K, Shigemori M (1999) Pineal malignant rhabdoid tumor with chondroid formation in an adult. Pathol Int 49:1114–1118PubMedCrossRef Sugita Y, Takahashi Y, Hayashi I, Morimatsu M, Okamoto K, Shigemori M (1999) Pineal malignant rhabdoid tumor with chondroid formation in an adult. Pathol Int 49:1114–1118PubMedCrossRef
20.
Zurück zum Zitat Bruch LA, Hill DA, Cai DX, Levy BK, Dehner LP, Perry A (2001) A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors. Hum Pathol 32:156–162PubMedCrossRef Bruch LA, Hill DA, Cai DX, Levy BK, Dehner LP, Perry A (2001) A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors. Hum Pathol 32:156–162PubMedCrossRef
21.
Zurück zum Zitat Kachhara R, Retnam TM, Kumar S, Nair S, Bhattacharya RN, Krishnamoorthy T, Radhakrishnan VV (2003) Rhabdoid tumor of the thalamus. Neurol India 51:273–274PubMed Kachhara R, Retnam TM, Kumar S, Nair S, Bhattacharya RN, Krishnamoorthy T, Radhakrishnan VV (2003) Rhabdoid tumor of the thalamus. Neurol India 51:273–274PubMed
22.
Zurück zum Zitat Erickson ML, Johnson R, Bannykh SI, de Lotbiniere A, Kim JH (2005) Malignant rhabdoid tumor in a pregnant adult female: literature review of central nervous system rhabdoid tumors. J Neurooncol 74:311–319PubMedCrossRef Erickson ML, Johnson R, Bannykh SI, de Lotbiniere A, Kim JH (2005) Malignant rhabdoid tumor in a pregnant adult female: literature review of central nervous system rhabdoid tumors. J Neurooncol 74:311–319PubMedCrossRef
23.
Zurück zum Zitat Bhattacharjee M, Hicks J, Dauser R, Strother D, Chintagumpala M, Horowitz M, Cooley L, Vogel H (1997) Primary malignant rhabdoid tumor of the central nervous system. Ultrastruct Pathol 21:361–368PubMedCrossRef Bhattacharjee M, Hicks J, Dauser R, Strother D, Chintagumpala M, Horowitz M, Cooley L, Vogel H (1997) Primary malignant rhabdoid tumor of the central nervous system. Ultrastruct Pathol 21:361–368PubMedCrossRef
24.
Zurück zum Zitat Parmar H, Hawkins C, Bouffet E, Rutka J, Shroff M (2006) Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors. Pediatr Radiol 36:126–132PubMedCrossRef Parmar H, Hawkins C, Bouffet E, Rutka J, Shroff M (2006) Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors. Pediatr Radiol 36:126–132PubMedCrossRef
25.
Zurück zum Zitat Lee MC, Park SK, Lim JS, Jung S, Kim JH, Woo YJ, Lee JS, Kim HI, Jeong MJ, Choi HY (2002) Atypical teratoid/rhabdoid tumor of the central nervous system: clinico-pathological study. Neuropathology 22:252–260PubMedCrossRef Lee MC, Park SK, Lim JS, Jung S, Kim JH, Woo YJ, Lee JS, Kim HI, Jeong MJ, Choi HY (2002) Atypical teratoid/rhabdoid tumor of the central nervous system: clinico-pathological study. Neuropathology 22:252–260PubMedCrossRef
26.
Zurück zum Zitat Medjkane S, Novikov E, Versteege I, Delattre O (2004) The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. Cancer Res 64:3406–3413PubMedCrossRef Medjkane S, Novikov E, Versteege I, Delattre O (2004) The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. Cancer Res 64:3406–3413PubMedCrossRef
27.
Zurück zum Zitat Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA (2005) INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol 18:951–958PubMedCrossRef Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA (2005) INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol 18:951–958PubMedCrossRef
28.
Zurück zum Zitat Biegel JA, Kalpana G, Knudsen ES, Packer RJ, Roberts CW, Thiele CJ, Weissman B, Smith M (2002) The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res 62:323–328PubMed Biegel JA, Kalpana G, Knudsen ES, Packer RJ, Roberts CW, Thiele CJ, Weissman B, Smith M (2002) The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res 62:323–328PubMed
29.
Zurück zum Zitat Lee CH, Murphy MR, Lee JS, Chung JH (1999) Targeting a SWI/SNF-related chromatin remodeling complex to the beta-globin promoter in erythroid cells. Proc Natl Acad Sci USA 96:12311–12315PubMedCrossRef Lee CH, Murphy MR, Lee JS, Chung JH (1999) Targeting a SWI/SNF-related chromatin remodeling complex to the beta-globin promoter in erythroid cells. Proc Natl Acad Sci USA 96:12311–12315PubMedCrossRef
30.
Zurück zum Zitat Muchardt C, Yaniv M (1999) The mammalian SWI/SNF complex and the control of cell growth. Semin Cell Dev Biol 10:189–195PubMedCrossRef Muchardt C, Yaniv M (1999) The mammalian SWI/SNF complex and the control of cell growth. Semin Cell Dev Biol 10:189–195PubMedCrossRef
31.
Zurück zum Zitat Phelan ML, Sif S, Narlikar GJ, Kingston RE (1999) Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 3:247–253PubMedCrossRef Phelan ML, Sif S, Narlikar GJ, Kingston RE (1999) Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 3:247–253PubMedCrossRef
32.
Zurück zum Zitat Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP (1994) Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266:2002–2006PubMedCrossRef Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP (1994) Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266:2002–2006PubMedCrossRef
33.
Zurück zum Zitat Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, Ghaffari S, Iliev D, Penn B, Woodland AM, Smith R, Salada G, Carillo A, Laity K, Gupte J, Swedlund B, Tavtigian SV, Teng DH, Lees E (2000) BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 60:6171–6177PubMed Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, Ghaffari S, Iliev D, Penn B, Woodland AM, Smith R, Salada G, Carillo A, Laity K, Gupte J, Swedlund B, Tavtigian SV, Teng DH, Lees E (2000) BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 60:6171–6177PubMed
34.
Zurück zum Zitat Knudsen ES, Buckmaster C, Chen TT, Feramisco JR, Wang JY (1998) Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev 12:2278–2292PubMedCrossRef Knudsen ES, Buckmaster C, Chen TT, Feramisco JR, Wang JY (1998) Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev 12:2278–2292PubMedCrossRef
35.
Zurück zum Zitat Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, Knudsen ES (2000) BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA 97:7748–7753PubMedCrossRef Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, Knudsen ES (2000) BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA 97:7748–7753PubMedCrossRef
36.
Zurück zum Zitat Parham DM, Weeks DA, Beckwith JB (1994) The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol 18:1010–1029PubMedCrossRef Parham DM, Weeks DA, Beckwith JB (1994) The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol 18:1010–1029PubMedCrossRef
37.
Zurück zum Zitat Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer BW, Walter AW, Rorke LB, Biegel JA (2004) Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 22:2877–2884PubMedCrossRef Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer BW, Walter AW, Rorke LB, Biegel JA (2004) Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 22:2877–2884PubMedCrossRef
38.
Zurück zum Zitat Allen JC, Judkins AR, Rosenblum MK, Biegel JA (2006) Atypical teratoid/rhabdoid tumor evolving from an optic pathway ganglioglioma: case study. Neuro Oncol 8:79–82PubMedCrossRef Allen JC, Judkins AR, Rosenblum MK, Biegel JA (2006) Atypical teratoid/rhabdoid tumor evolving from an optic pathway ganglioglioma: case study. Neuro Oncol 8:79–82PubMedCrossRef
39.
Zurück zum Zitat Litman DA, Bhuta S, Barsky SH (1993) Synchronous occurrence of malignant rhabdoid tumor two decades after Wilms’ tumor irradiation. Am J Surg Pathol 17:729–737PubMedCrossRef Litman DA, Bhuta S, Barsky SH (1993) Synchronous occurrence of malignant rhabdoid tumor two decades after Wilms’ tumor irradiation. Am J Surg Pathol 17:729–737PubMedCrossRef
Metadaten
Titel
Atypical teratoid rhabdoid tumor (AT/RT) in adults: review of four cases
verfasst von
Addisalem T. Makuria
Elisabeth J. Rushing
Kevin M. McGrail
Dan-Paul Hartmann
Norio Azumi
Metin Ozdemirli
Publikationsdatum
01.07.2008
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2008
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-008-9571-z

Weitere Artikel der Ausgabe 3/2008

Journal of Neuro-Oncology 3/2008 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.